Avoro Capital Advisors’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-4,250
| Closed | -$630K | – | 37 |
|
2019
Q1 | $630K | Hold |
4,250
| – | – | 0.03% | 31 |
|
2018
Q4 | $340K | Sell |
4,250
-22
| -0.5% | -$1.76K | 0.02% | 33 |
|
2018
Q3 | $670K | Hold |
4,272
| – | – | 0.03% | 42 |
|
2018
Q2 | $578K | Hold |
4,272
| – | – | 0.02% | 40 |
|
2018
Q1 | $608K | Hold |
4,272
| – | – | 0.03% | 48 |
|
2017
Q4 | $889K | Hold |
4,272
| – | – | 0.06% | 42 |
|
2017
Q3 | $936K | Hold |
4,272
| – | – | 0.07% | 36 |
|
2017
Q2 | $684K | Hold |
4,272
| – | – | 0.09% | 39 |
|
2017
Q1 | $1.83M | Hold |
4,272
| – | – | 0.23% | 37 |
|
2016
Q4 | $2.06M | Buy |
4,272
+1,454
| +52% | +$700K | 0.42% | 31 |
|
2016
Q3 | $1.92M | Sell |
2,818
-99
| -3% | -$67.3K | 0.34% | 34 |
|
2016
Q2 | $1.59M | Buy |
+2,917
| New | +$1.59M | 0.35% | 29 |
|